51 | | - | removed from the specified entity. 7 |
---|
52 | | - | (B) Whether an entity is an "affiliate" does not depend on 8 |
---|
53 | | - | the percentage or form of ownership interest or any allocation of membership 9 |
---|
54 | | - | or ownership between entities, but it is the existence of control or common 10 |
---|
55 | | - | control that is the sole determinative factor; 11 |
---|
56 | | - | (17)(A) "Carve-out network" means a subset of a pharmacy 12 |
---|
57 | | - | benefits manager's network that: 13 |
---|
58 | | - | (i) Is created by the pharmacy benefits manager; and 14 |
---|
59 | | - | (ii) Limits access to a certain pharmacy or 15 |
---|
60 | | - | pharmacist for a specific drug or category of drugs. 16 |
---|
61 | | - | (B) "Carve-out network" includes any network that 17 |
---|
62 | | - | restricts enrollee access to in -person pharmacy services within this state by 18 |
---|
63 | | - | offering only limited methods of obtaining a prescription drug, including 19 |
---|
64 | | - | mail-order only options, while presenting the appearance of a full network of 20 |
---|
65 | | - | available pharmacies; 21 |
---|
66 | | - | (18) "Enrollee" means an individual who is entitled to receive 22 |
---|
67 | | - | healthcare services under the terms of a health benefit plan; 23 |
---|
68 | | - | (19)(A) "Ghost network" means a pharmacy benefits manager 24 |
---|
69 | | - | network that includes a pharmacy or pharmacist as a participating provider 25 |
---|
70 | | - | when that participating provider is: 26 |
---|
71 | | - | (i) Not accepting new patients; 27 |
---|
72 | | - | (ii) No longer in practice; or 28 |
---|
73 | | - | (iii) Otherwise unavailable to or restricted from 29 |
---|
74 | | - | providing services to enrollees in this state. 30 |
---|
75 | | - | (B) "Ghost network" includes a pharmacy network in which a 31 |
---|
76 | | - | significant number of listed participating providers are not accessible to 32 |
---|
77 | | - | enrollees within a reasonable time frame or geographic distance; 33 |
---|
78 | | - | (20) "Healthcare payor affiliate" means a pharmacy or pharmacist 34 |
---|
79 | | - | that directly or indirectly, through one (1) or more intermediaries, owns or 35 |
---|
80 | | - | controls, is owned or controlled by, or is under common ownership or control 36 As Engrossed: H3/19/25 H4/1/25 SB104 |
---|
| 47 | + | removed from the specified entity; 7 |
---|
| 48 | + | (17)(A) "Carve-out network" means a subset of a pharmacy 8 |
---|
| 49 | + | benefits manager's network that: 9 |
---|
| 50 | + | (i) Is created by the pharmacy benefits manager; and 10 |
---|
| 51 | + | (ii) Limits access to a certain pharmacy or 11 |
---|
| 52 | + | pharmacist for a specific drug or category of drugs. 12 |
---|
| 53 | + | (B) "Carve-out network" includes any network that 13 |
---|
| 54 | + | restricts enrollee access to in -person pharmacy services within this state by 14 |
---|
| 55 | + | offering only limited methods of obtaining a prescription drug, including 15 |
---|
| 56 | + | mail-order only options, while presenting the appearance of a full network of 16 |
---|
| 57 | + | available pharmacies; 17 |
---|
| 58 | + | (18) "Enrollee" means an individual who is entitled to receive 18 |
---|
| 59 | + | healthcare services under the terms of a health benefit plan; 19 |
---|
| 60 | + | (19)(A) "Ghost network" means a pharmacy benefits manager 20 |
---|
| 61 | + | network that includes a pharmacy or pharmacist as a participating provider 21 |
---|
| 62 | + | when that participating provider is: 22 |
---|
| 63 | + | (i) Not accepting new patients; 23 |
---|
| 64 | + | (ii) No longer in practice; or 24 |
---|
| 65 | + | (iii) Otherwise unavailable to or restricted from 25 |
---|
| 66 | + | providing services to enrollees in this state. 26 |
---|
| 67 | + | (B) "Ghost network" includes a pharmacy network in which a 27 |
---|
| 68 | + | significant number of listed participating providers are not accessible to 28 |
---|
| 69 | + | enrollees within a reasonable time frame or geographic distance; 29 |
---|
| 70 | + | (20) "Healthcare payor affiliate" means a pharmacy or pharmacist 30 |
---|
| 71 | + | that directly or indirectly, through one (1) or more intermediaries, owns or 31 |
---|
| 72 | + | controls, is owned or controlled by, or is under common ownership or control 32 |
---|
| 73 | + | with a healthcare payor; and 33 |
---|
| 74 | + | (21)(A) "Self-administered prescription drug" means a 34 |
---|
| 75 | + | pharmaceutical that when prescribed does not require assistance by a third 35 |
---|
| 76 | + | party to administer and can be dispensed by a pharmacy or pharmacist to an 36 SB104 |
---|
85 | | - | with a healthcare payor; and 1 |
---|
86 | | - | (21)(A) "Self-administered prescription drug" means a 2 |
---|
87 | | - | pharmaceutical that when prescribed does not require assistance by a third 3 |
---|
88 | | - | party to administer and can be dispensed by a pharmacy or pharmacist to an 4 |
---|
89 | | - | enrollee for self-administration under federal and state laws and 5 |
---|
90 | | - | regulations. 6 |
---|
91 | | - | (B) "Self-administered prescription drug" does not include 7 |
---|
92 | | - | over-the-counter medications that do not require a prescription. 8 |
---|
93 | | - | 9 |
---|
94 | | - | SECTION 3. Arkansas Code § 23 -92-506(b), concerning prohibited 10 |
---|
95 | | - | practices under the Arkansas Pharmacy Benefits Manager Licensure Act, is 11 |
---|
96 | | - | amended to add an additional subdivision to read as follows: 12 |
---|
97 | | - | (9) Unless reviewed and approved by the commissioner in 13 |
---|
98 | | - | coordination with the board, require pharmacy accreditation standards or 14 |
---|
99 | | - | certification requirements inconsistent with, more stringent than, or in 15 |
---|
100 | | - | addition to requirements of the board. 16 |
---|
101 | | - | 17 |
---|
102 | | - | SECTION 4. Arkansas Code Title 23, Chapter 92, Subchapter 5, is 18 |
---|
103 | | - | amended to add additional sections to read as follows: 19 |
---|
104 | | - | 23-92-512. Unfair and deceptive trade practices. 20 |
---|
105 | | - | (a)(1) A healthcare payor, healthcare payor affiliate, pharmacy 21 |
---|
106 | | - | benefits manager, or pharmacy benefits manager affiliate shall not engage in 22 |
---|
107 | | - | unfair or deceptive trade practices in the administration of pharmacy 23 |
---|
108 | | - | benefits. 24 |
---|
109 | | - | (2) Unfair or deceptive trade practices under subdivision (a)(1) 25 |
---|
110 | | - | of this section include without limitation: 26 |
---|
111 | | - | (A) Requiring an enrollee to utilize a particular 27 |
---|
112 | | - | pharmacy benefits manager affiliate; 28 |
---|
113 | | - | (B) Requiring a pharmacy or pharmacist to forward or 29 |
---|
114 | | - | retransmit a prescription to a specific healthcare payor affiliate or 30 |
---|
115 | | - | pharmacy benefits manager affiliate unless the receiving healthcare payor 31 |
---|
116 | | - | affiliate or pharmacy benefits manager affiliate can provide verifiable 32 |
---|
117 | | - | documentation of the enrollee's consent to use that specific pharmacy; 33 |
---|
118 | | - | (C) Implementing a policy or protocol that unreasonably 34 |
---|
119 | | - | restricts an enrollee's choice of pharmacy within a pharmacy benefits manager 35 |
---|
120 | | - | network, if: 36 As Engrossed: H3/19/25 H4/1/25 SB104 |
---|
| 154 | + | 5 01/27/2025 7:44:32 AM ANS087 |
---|
| 155 | + | assigned representative’s rights to seek an exception to or to appeal a 1 |
---|
| 156 | + | coverage decision or restriction with his or her health benefit plan. 2 |
---|
| 157 | + | (2) A healthcare payor, healthcare payor affiliate, pharmacy 3 |
---|
| 158 | + | benefits manager, or pharmacy benefits manager affiliate shall ensure that: 4 |
---|
| 159 | + | (A) The processes for seeking an exception and filing an 5 |
---|
| 160 | + | appeal are clearly communicated to patients in a publicly accessible manner 6 |
---|
| 161 | + | on its website; 7 |
---|
| 162 | + | (B) The information necessary to utilize the processes 8 |
---|
| 163 | + | under subdivision (b)(2)(A) of this section is presented in a manner that is 9 |
---|
| 164 | + | understandable and not hidden or obscured; and 10 |
---|
| 165 | + | (C) An enrollee is not hindered or obstructed from 11 |
---|
| 166 | + | exercising the rights granted to the enrollee under the enrollee's health 12 |
---|
| 167 | + | benefit plan. 13 |
---|
| 168 | + | (c)(1) A healthcare payor shall not prohibit, restrict, or impede an 14 |
---|
| 169 | + | enrollee’s or an enrollee’s authorized representative’s ability to: 15 |
---|
| 170 | + | (A) Discuss the enrollee's health benefit plan, including 16 |
---|
| 171 | + | prescription drug benefits, with the healthcare payor or its authorized 17 |
---|
| 172 | + | representatives; 18 |
---|
| 173 | + | (B) Obtain necessary exceptions, approvals, 19 |
---|
| 174 | + | authorizations, or related information to access the enrollee's benefits; or 20 |
---|
| 175 | + | (C) Appeal decisions regarding the enrollee's benefits 21 |
---|
| 176 | + | coverage decisions as provided under the terms of the enrollee's health 22 |
---|
| 177 | + | benefit plan. 23 |
---|
| 178 | + | (2) The healthcare payor shall ensure that an enrollee has 24 |
---|
| 179 | + | reasonable access to the discussions, approvals, and appeals processes 25 |
---|
| 180 | + | regardless of the pharmacy benefits manager, affiliate, or third -party 26 |
---|
| 181 | + | administrator selected to administer prescription benefits. 27 |
---|
| 182 | + | (3) It is an unfair and deceptive trade practice for a 28 |
---|
| 183 | + | healthcare payor to delegate responsibilities in a manner that obstructs, 29 |
---|
| 184 | + | hinders, or prevents an enrollee from exercising the enrollee's rights under 30 |
---|
| 185 | + | his or her health benefit plan. 31 |
---|
| 186 | + | (d)(1) A pharmacy benefits manager and pharmacy benefits manager 32 |
---|
| 187 | + | affiliate shall adhere to all applicable federal and state privacy laws when 33 |
---|
| 188 | + | communicating with an enrollee. 34 |
---|
| 189 | + | (2) A pharmacy benefits manager and pharmacy benefits manager 35 |
---|
| 190 | + | affiliate shall not use enrollee information for marketing purposes without 36 SB104 |
---|
125 | | - | (i)(a) The pharmacy meets the pharmacy benefits 1 |
---|
126 | | - | manager network's relevant and reasonable terms of participation 2 |
---|
127 | | - | requirements. 3 |
---|
128 | | - | (b) A disagreement or concern regarding 4 |
---|
129 | | - | whether relevant and reasonable terms of participation requirements are 5 |
---|
130 | | - | relevant and reasonable shall be determined by the Insurance Commissioner; 6 |
---|
131 | | - | and 7 |
---|
132 | | - | (ii) The pharmacy has existing approval to dispense 8 |
---|
133 | | - | one (1) or more self -administered prescription drugs in one (1) or more 9 |
---|
134 | | - | pharmacy benefits manager networks for the underlying health benefit plan; 10 |
---|
135 | | - | (D)(i) Providing an incentive or imposing a penalty that 11 |
---|
136 | | - | effectively coerces or pressures an enrollee to use a particular healthcare 12 |
---|
137 | | - | payor affiliate or pharmacy benefits manager affiliate. 13 |
---|
138 | | - | (ii) Adjustments to an enrollee's cost -sharing 14 |
---|
139 | | - | responsibilities, including copayments, coinsurance, or deductibles, that are 15 |
---|
140 | | - | part of the health benefit plan's design are not considered incentives or 16 |
---|
141 | | - | penalties under subdivision (a)(2)(D)(i) of this section; 17 |
---|
142 | | - | (E) Failing to disclose to an enrollee the options 18 |
---|
143 | | - | available for obtaining prescription drugs within the pharmacy benefits 19 |
---|
144 | | - | manager network; 20 |
---|
145 | | - | (F) Disclosing, sharing, or otherwise making available 21 |
---|
146 | | - | enrollee information or enrollee -identifiable prescription information 22 |
---|
147 | | - | submitted by a pharmacist or pharmacy to a healthcare payor affiliate or 23 |
---|
148 | | - | pharmacy benefits manager affiliate without the written consent of the 24 |
---|
149 | | - | enrollee; 25 |
---|
150 | | - | (G) Using or disclosing enrollee information or enrollee -26 |
---|
151 | | - | identifiable prescription information for marketing or solicitation purposes 27 |
---|
152 | | - | without the written consent of the enrollee; and 28 |
---|
153 | | - | (H)(i) Engaging in any conduct that unlawfully restricts, 29 |
---|
154 | | - | limits, or interferes with an enrollee's right to choose a pharmacy or 30 |
---|
155 | | - | pharmacist, including without limitation actions that violate federal law or 31 |
---|
156 | | - | state law or improperly steer enrollees to a specific pharmacy or pharmacist. 32 |
---|
157 | | - | (ii) The prohibition under subdivision (a)(2)(H)(i) 33 |
---|
158 | | - | of this section does not apply to a change in patient cost -sharing 34 |
---|
159 | | - | obligations, including copayments, coinsurance, or deductibles, that are 35 |
---|
160 | | - | permitted under applicable law. 36 As Engrossed: H3/19/25 H4/1/25 SB104 |
---|
| 268 | + | 8 01/27/2025 7:44:32 AM ANS087 |
---|
| 269 | + | that: 1 |
---|
| 270 | + | (i) Is based on the number of Arkansas residents 2 |
---|
| 271 | + | serviced by the healthcare payor or pharmacy benefits manager; and 3 |
---|
| 272 | + | (ii) Does not exceed one hundred thousand dollars 4 |
---|
| 273 | + | ($100,000) per violation. 5 |
---|
| 274 | + | 6 |
---|
| 275 | + | 23-92-514. Patient accommodation and nonrestriction clause. 7 |
---|
| 276 | + | (a) A healthcare payor or pharmacy benefits manager shall not enforce 8 |
---|
| 277 | + | the use of a particular healthcare payor affiliate or pharmacy benefits 9 |
---|
| 278 | + | manager affiliate or otherwise restrict an enrollee's choice of pharmacist or 10 |
---|
| 279 | + | pharmacy without considering the enrollee's individual limitations, including 11 |
---|
| 280 | + | without limitation: 12 |
---|
| 281 | + | (1) Medical limitations, including chronic illnesses, temporary 13 |
---|
| 282 | + | or permanent disabilities, or conditions requiring specialized care or that 14 |
---|
| 283 | + | impair cognitive or motor functions; 15 |
---|
| 284 | + | (2) Complex therapies, when the self -administered prescription 16 |
---|
| 285 | + | drug is one (1) of multiple pharmaceuticals provided to an enrollee receiving 17 |
---|
| 286 | + | treatment and mailing the individual pharmaceutical has the potential to 18 |
---|
| 287 | + | interfere with the appropriate and timely administration requirements; 19 |
---|
| 288 | + | (3) Physical limitations, including mobility impairments or 20 |
---|
| 289 | + | inability to retrieve mail or other deliveries without assistance or risk for 21 |
---|
| 290 | + | physical harm to self while retrieving mail or other deliveries; 22 |
---|
| 291 | + | (4) Socioeconomic limitations, including financial hardships, 23 |
---|
| 292 | + | lack of reliable transportation, lack of a caregiver, or other socioeconomic 24 |
---|
| 293 | + | barriers that may prohibit an enrollee from being present during delivery or 25 |
---|
| 294 | + | prohibit an enrollee from accessing the delivery location; 26 |
---|
| 295 | + | (5) Housing limitations, including homelessness, medical 27 |
---|
| 296 | + | confinement, incarceration, unstable housing situations, residences without 28 |
---|
| 297 | + | secure mail delivery options, or residences with shared mail facilities; 29 |
---|
| 298 | + | (6) Chain of custody, when a dispensing pharmacy cannot 30 |
---|
| 299 | + | guarantee that the recipient of the self -administered prescription drug will 31 |
---|
| 300 | + | be present according to federal and state laws and regulations; 32 |
---|
| 301 | + | (7) Prescribing provider order contradictions, when the 33 |
---|
| 302 | + | dispensing pharmacy is unable to guarantee that the prescribing provider's 34 |
---|
| 303 | + | orders will be followed if the self -administered prescription drug is 35 |
---|
| 304 | + | delivered, including situations in which the prescribing provider requires 36 SB104 |
---|
165 | | - | (b)(1) A healthcare payor, healthcare payor affiliate, pharmacy 1 |
---|
166 | | - | benefits manager, or pharmacy benefits manager affiliate shall not impose 2 |
---|
167 | | - | restrictive terms or conditions that limit an enrollee's or an enrollee’s 3 |
---|
168 | | - | assigned representative’s rights to seek an exception to or to appeal a 4 |
---|
169 | | - | coverage decision or restriction with his or her health benefit plan. 5 |
---|
170 | | - | (2) A healthcare payor, healthcare payor affiliate, pharmacy 6 |
---|
171 | | - | benefits manager, or pharmacy benefits manager affiliate shall ensure that: 7 |
---|
172 | | - | (A) The processes for seeking an exception and filing an 8 |
---|
173 | | - | appeal are clearly communicated to patients in a publicly accessible manner 9 |
---|
174 | | - | on its website; 10 |
---|
175 | | - | (B) The information necessary to utilize the processes 11 |
---|
176 | | - | under subdivision (b)(2)(A) of this section is presented in a manner that is 12 |
---|
177 | | - | understandable and not hidden or obscured; and 13 |
---|
178 | | - | (C) An enrollee is not hindered or obstructed from 14 |
---|
179 | | - | exercising the rights granted to the enrollee under the enrollee's health 15 |
---|
180 | | - | benefit plan. 16 |
---|
181 | | - | (c)(1) A healthcare payor shall not prohibit, restrict, or impede an 17 |
---|
182 | | - | enrollee’s or an enrollee’s authorized representative’s ability to: 18 |
---|
183 | | - | (A) Discuss the enrollee's health benefit plan, including 19 |
---|
184 | | - | prescription drug benefits, with the healthcare payor or its authorized 20 |
---|
185 | | - | representatives; 21 |
---|
186 | | - | (B) Obtain necessary exceptions, approvals, 22 |
---|
187 | | - | authorizations, or related information to access the enrollee's benefits; or 23 |
---|
188 | | - | (C) Appeal decisions regarding the enrollee's benefits 24 |
---|
189 | | - | coverage decisions as provided under the terms of the enrollee's health 25 |
---|
190 | | - | benefit plan. 26 |
---|
191 | | - | (2) The healthcare payor shall ensure that an enrollee has 27 |
---|
192 | | - | reasonable access to the discussions, approvals, and appeals processes 28 |
---|
193 | | - | regardless of the pharmacy benefits manager, affiliate, or third -party 29 |
---|
194 | | - | administrator selected to administer prescription benefits. 30 |
---|
195 | | - | (3) It is an unfair and deceptive trade practice for a 31 |
---|
196 | | - | healthcare payor to delegate responsibilities in a manner that obstructs, 32 |
---|
197 | | - | hinders, or prevents an enrollee from exercising the enrollee's rights under 33 |
---|
198 | | - | his or her health benefit plan. 34 |
---|
199 | | - | (d)(1) A pharmacy benefits manager and pharmacy benefits manager 35 |
---|
200 | | - | affiliate shall adhere to all applicable federal and state privacy laws when 36 As Engrossed: H3/19/25 H4/1/25 SB104 |
---|
201 | | - | |
---|
202 | | - | 6 04-01-2025 14:34:50 ANS087 |
---|
203 | | - | |
---|
204 | | - | |
---|
205 | | - | communicating with an enrollee. 1 |
---|
206 | | - | (2) A pharmacy benefits manager and pharmacy benefits manager 2 |
---|
207 | | - | affiliate shall not use enrollee information for marketing purposes without 3 |
---|
208 | | - | the written consent of the enrollee. 4 |
---|
209 | | - | (e) A pharmacy benefits manager and pharmacy benefits manager 5 |
---|
210 | | - | affiliate shall comply with the timely processing of complaints and appeals 6 |
---|
211 | | - | as established by rule of the commissioner. 7 |
---|
212 | | - | (f)(1) The commissioner may promulgate rules necessary to implement, 8 |
---|
213 | | - | administer, and enforce this section. 9 |
---|
214 | | - | (2) Rules that the commissioner may adopt under this section 10 |
---|
215 | | - | include without limitation rules relating to implementing a penalty structure 11 |
---|
216 | | - | for a healthcare payor, healthcare payor affiliate, pharmacy benefits 12 |
---|
217 | | - | manager, or pharmacy benefits manager affiliate that fails to comply with 13 |
---|
218 | | - | this section that is based on the number of Arkansas residents serviced by 14 |
---|
219 | | - | the healthcare payor, healthcare payor affiliate, pharmacy benefits manager, 15 |
---|
220 | | - | or pharmacy benefits manager affiliate. 16 |
---|
221 | | - | (g)(1) A violation of this subchapter is an unfair and deceptive act 17 |
---|
222 | | - | or practice as defined by the Deceptive Trade Practices Act, § 4 -88-101 et 18 |
---|
223 | | - | seq. 19 |
---|
224 | | - | (2) All remedies, penalties, and authority granted to the 20 |
---|
225 | | - | Attorney General under the Deceptive Trade Practices Act, § 4 -88-101 et seq., 21 |
---|
226 | | - | shall be available to the Attorney General for the enforcement of this 22 |
---|
227 | | - | subchapter. 23 |
---|
| 382 | + | 11 01/27/2025 7:44:32 AM ANS087 |
---|
| 383 | + | activity; 1 |
---|
| 384 | + | (3) Solicits, advises, encourages, or coerces another person or 2 |
---|
| 385 | + | entity to perform the prohibited activity; 3 |
---|
| 386 | + | (4) Aids or attempts to aid another person or entity in 4 |
---|
| 387 | + | performing a prohibited activity; or 5 |
---|
| 388 | + | (5) Indirectly performs the prohibited activity. 6 |
---|
| 389 | + | 7 |
---|
| 390 | + | SECTION 5. EMERGENCY CLAUSE. It is found and determined by the 8 |
---|
| 391 | + | General Assembly of the State of Arkansas that an enrollee's access to 9 |
---|
| 392 | + | prescription medications is of immediate concern; that undue restrictions on 10 |
---|
| 393 | + | pharmacies and pharmacists hinder patient care; and that this act is 11 |
---|
| 394 | + | immediately necessary to protect an enrollee's rights and ensure timely 12 |
---|
| 395 | + | access to medications. Therefore, an emergency is declared to exist, and this 13 |
---|
| 396 | + | act being immediately necessary for the preservation of the public peace, 14 |
---|
| 397 | + | health, and safety shall become effective on: 15 |
---|
| 398 | + | (1) The date of its approval by the Governor; 16 |
---|
| 399 | + | (2) If the bill is neither approved nor vetoed by the Governor, 17 |
---|
| 400 | + | the expiration of the period of time during which the Governor may veto the 18 |
---|
| 401 | + | bill; or 19 |
---|
| 402 | + | (3) If the bill is vetoed by the Governor and the veto is 20 |
---|
| 403 | + | overridden, the date the last house overrides the veto. 21 |
---|
| 404 | + | 22 |
---|
| 405 | + | 23 |
---|
229 | | - | 23-92-513. Prohibition of ghost networks. 25 |
---|
230 | | - | (a)(1) A pharmacy benefits manager shall not create, utilize, or 26 |
---|
231 | | - | maintain a ghost network within this state. 27 |
---|
232 | | - | (2) For purposes of this section, a network shall not be 28 |
---|
233 | | - | considered a ghost network if the network includes at least one (1) mail -29 |
---|
234 | | - | order pharmacy option and one (1) in -person pharmacy option that is 30 |
---|
235 | | - | physically located in this state if both the mail -order pharmacy option and 31 |
---|
236 | | - | the in-person pharmacy option are: 32 |
---|
237 | | - | (A) Accepting new patients; and 33 |
---|
238 | | - | (B) Otherwise available to an enrollee in this state. 34 |
---|
239 | | - | (b)(1) A healthcare payor or pharmacy benefits manager shall not 35 |
---|
240 | | - | create, utilize, or maintain a carve -out network within this state by: 36 As Engrossed: H3/19/25 H4/1/25 SB104 |
---|
241 | | - | |
---|
242 | | - | 7 04-01-2025 14:34:50 ANS087 |
---|
243 | | - | |
---|
244 | | - | |
---|
245 | | - | (A) Limiting enrollee access to specific pharmacies or 1 |
---|
246 | | - | pharmacists for self -administered prescription drugs when an enrollee is 2 |
---|
247 | | - | directed to use a healthcare payor affiliate, pharmacy benefits manager 3 |
---|
248 | | - | affiliate, or other limited option while the pharmacy benefits manager 4 |
---|
249 | | - | network appears to offer a full range of pharmacist services; 5 |
---|
250 | | - | (B) Failing to provide adequate access to pharmacy services for 6 |
---|
251 | | - | all covered self-administered prescription drugs, including through a 7 |
---|
252 | | - | licensed pharmacy physically located within this state; or 8 |
---|
253 | | - | (C) Representing that a broad network of pharmacies or 9 |
---|
254 | | - | pharmacists is available if, in practice, access to certain self -administered 10 |
---|
255 | | - | prescription drugs is restricted to a carve -out network that lacks sufficient 11 |
---|
256 | | - | in-state providers accessible to an enrollee. 12 |
---|
257 | | - | (2) For purposes of this section, a network shall not be 13 |
---|
258 | | - | considered a carve-out network if the network includes at least one (1) mail -14 |
---|
259 | | - | order pharmacy option and one (1) in -person pharmacy option that is 15 |
---|
260 | | - | physically located in this state if both the mail -order pharmacy option and 16 |
---|
261 | | - | the in-person pharmacy option are: 17 |
---|
262 | | - | (A) Accepting new patients; and 18 |
---|
263 | | - | (B) Otherwise available to an enrollee in this state.19 |
---|
264 | | - | (c) A healthcare payor or pharmacy benefits manager shall ensure that 20 |
---|
265 | | - | its pharmacy benefits manager network of participating pharmacists and 21 |
---|
266 | | - | pharmacies: 22 |
---|
267 | | - | (1) Accurately reflects the availability of pharmacists and 23 |
---|
268 | | - | pharmacies actively accepting new patients; 24 |
---|
269 | | - | (2) Provides an enrollee with reasonable access to pharmacist 25 |
---|
270 | | - | services within this state, including options for in -person consultations and 26 |
---|
271 | | - | medication pickup from a licensed pharmacist or pharmacy in this state; 27 |
---|
272 | | - | (3) Is not solely serviced by a mail -order pharmacy; and 28 |
---|
273 | | - | (4) Is not solely serviced by a pharmacy benefits manager 29 |
---|
274 | | - | affiliate or healthcare payor affiliate. 30 |
---|
275 | | - | (d) A healthcare payor or pharmacy benefits manager shall: 31 |
---|
276 | | - | (1) Regularly verify and update its pharmacy benefits manager 32 |
---|
277 | | - | network directory to reflect the current availability of participating 33 |
---|
278 | | - | pharmacists and pharmacies; 34 |
---|
279 | | - | (2) Remove a pharmacist or pharmacy from its pharmacy benefits 35 |
---|
280 | | - | manager network directory if that pharmacist or pharmacy is: 36 As Engrossed: H3/19/25 H4/1/25 SB104 |
---|
281 | | - | |
---|
282 | | - | 8 04-01-2025 14:34:50 ANS087 |
---|
283 | | - | |
---|
284 | | - | |
---|
285 | | - | (A) Not accepting new patients; 1 |
---|
286 | | - | (B) No longer in practice; or 2 |
---|
287 | | - | (C) Otherwise unavailable to provide services; and 3 |
---|
288 | | - | (3) Provide accurate and accessible information to an enrollee 4 |
---|
289 | | - | regarding participating pharmacists and pharmacies within the pharmacy 5 |
---|
290 | | - | benefits manager network in a publicly accessible manner on its website. 6 |
---|
291 | | - | (e)(1) The Insurance Commissioner may promulgate rules necessary to 7 |
---|
292 | | - | implement, administer, and enforce this section. 8 |
---|
293 | | - | (2) Rules that the commissioner may adopt under this section 9 |
---|
294 | | - | include without limitation rules relating to: 10 |
---|
295 | | - | (A) Requiring a healthcare payor and pharmacy benefits 11 |
---|
296 | | - | manager to submit periodic reports on pharmacy benefits manager network 12 |
---|
297 | | - | adequacy and accessibility; 13 |
---|
298 | | - | (B) Investigating a complaint regarding a ghost network 14 |
---|
299 | | - | and taking appropriate enforcement action; and 15 |
---|
300 | | - | (C) Implementing a penalty structure for a healthcare 16 |
---|
301 | | - | payor or pharmacy benefits manager that fails to comply with this section 17 |
---|
302 | | - | that: 18 |
---|
303 | | - | (i) Is based on the number of Arkansas residents 19 |
---|
304 | | - | serviced by the healthcare payor or pharmacy benefits manager; and 20 |
---|
305 | | - | (ii) Does not exceed one hundred thousand dollars 21 |
---|
306 | | - | ($100,000) per violation. 22 |
---|
307 | | - | 23 |
---|
308 | | - | 23-92-514. Patient accommodation and nonrestriction clause. 24 |
---|
309 | | - | (a) A healthcare payor or pharmacy benefits manager shall not enforce 25 |
---|
310 | | - | the use of a particular healthcare payor affiliate or pharmacy benefits 26 |
---|
311 | | - | manager affiliate without considering the enrollee's individual limitations, 27 |
---|
312 | | - | including without limitation: 28 |
---|
313 | | - | (1) Medical limitations, including chronic illnesses, temporary 29 |
---|
314 | | - | or permanent disabilities, or conditions requiring specialized care or that 30 |
---|
315 | | - | impair cognitive or motor functions; 31 |
---|
316 | | - | (2) Complex therapies, when the self -administered prescription 32 |
---|
317 | | - | drug is one (1) of multiple pharmaceuticals provided to an enrollee receiving 33 |
---|
318 | | - | treatment and mailing the individual pharmaceutical has the potential to 34 |
---|
319 | | - | interfere with the appropriate and timely administration requirements; 35 |
---|
320 | | - | (3) Physical limitations, including mobility impairments or 36 As Engrossed: H3/19/25 H4/1/25 SB104 |
---|
321 | | - | |
---|
322 | | - | 9 04-01-2025 14:34:50 ANS087 |
---|
323 | | - | |
---|
324 | | - | |
---|
325 | | - | inability to retrieve mail or other deliveries without assistance or risk for 1 |
---|
326 | | - | physical harm to self while retrieving mail or other deliveries; 2 |
---|
327 | | - | (4) Socioeconomic limitations, including financial hardships, 3 |
---|
328 | | - | lack of reliable transportation, lack of a caregiver, or other socioeconomic 4 |
---|
329 | | - | barriers that may prohibit an enrollee from being present during delivery or 5 |
---|
330 | | - | prohibit an enrollee from accessing the delivery location; 6 |
---|
331 | | - | (5) Housing limitations, including homelessness, medical 7 |
---|
332 | | - | confinement, incarceration, unstable housing situations, residences without 8 |
---|
333 | | - | secure mail delivery options, or residences with shared mail facilities; 9 |
---|
334 | | - | (6) Chain of custody, when a dispensing pharmacy cannot 10 |
---|
335 | | - | guarantee that the recipient of the self -administered prescription drug will 11 |
---|
336 | | - | be present according to federal and state laws and regulations; 12 |
---|
337 | | - | (7) Prescribing provider order contradictions, when the 13 |
---|
338 | | - | dispensing pharmacy is unable to guarantee that the prescribing provider's 14 |
---|
339 | | - | orders will be followed if the self -administered prescription drug is 15 |
---|
340 | | - | delivered, including situations in which the prescribing provider requires 16 |
---|
341 | | - | administration under direct supervision of a medical professional for a 17 |
---|
342 | | - | customarily self-administered prescription drug; 18 |
---|
343 | | - | (8) Medication storage and efficacy concerns, when the 19 |
---|
344 | | - | dispensing pharmacy is unable to guarantee that the enrollee will receive the 20 |
---|
345 | | - | self-administered prescription drug in a timely fashion that does not 21 |
---|
346 | | - | interfere with the environmental storage and transportation requirements 22 |
---|
347 | | - | denoted by the manufacturer of the pharmaceutical; and 23 |
---|
348 | | - | (9) Other relevant limitations, including mental health 24 |
---|
349 | | - | conditions, cognitive or behavioral impairments, or any other factors that 25 |
---|
350 | | - | impede or put at risk an enrollee's ability to receive, access, or administer 26 |
---|
351 | | - | his or her self-administered prescription drugs. 27 |
---|
352 | | - | (b)(1) An enrollee may obtain medications from a pharmacy of his or 28 |
---|
353 | | - | her choice when healthcare payor affiliate services or pharmacy benefits 29 |
---|
354 | | - | manager affiliate services are not suitable due to the limitations specified 30 |
---|
355 | | - | under subsection (a) of this section. 31 |
---|
356 | | - | (2) A healthcare payor or pharmacy benefits manager shall 32 |
---|
357 | | - | facilitate access to in -person pharmacy services without imposing additional 33 |
---|
358 | | - | costs or penalties on the enrollee. 34 |
---|
359 | | - | (c) A healthcare payor or pharmacy benefits manager shall not mandate 35 |
---|
360 | | - | the use of a healthcare payor affiliate or pharmacy benefits manager 36 As Engrossed: H3/19/25 H4/1/25 SB104 |
---|
361 | | - | |
---|
362 | | - | 10 04-01-2025 14:34:50 ANS087 |
---|
363 | | - | |
---|
364 | | - | |
---|
365 | | - | affiliate in cases in which use of a pharmacy benefits manager affiliate or 1 |
---|
366 | | - | healthcare payor affiliate would adversely affect the enrollee's ability to 2 |
---|
367 | | - | receive or administer his or her self -administered prescription drug safely 3 |
---|
368 | | - | and effectively, considering the patient's individual circumstances under 4 |
---|
369 | | - | subsection (a) of this section as determined by the enrollee's healthcare 5 |
---|
370 | | - | provider. 6 |
---|
371 | | - | (d) A healthcare payor and pharmacy benefits manager shall maintain 7 |
---|
372 | | - | compliance in all dispensing practices with: 8 |
---|
373 | | - | (1) The prescribing healthcare provider's orders; and 9 |
---|
374 | | - | (2) All applicable federal and state laws regarding medication 10 |
---|
375 | | - | dispensing and chain of custody. 11 |
---|
376 | | - | (e) A healthcare payor or pharmacy benefits manager shall not 12 |
---|
377 | | - | retaliate against an enrollee or healthcare provider for exercising his or 13 |
---|
378 | | - | her rights under this section by: 14 |
---|
379 | | - | (1) Increasing costs; 15 |
---|
380 | | - | (2) Denying services; or 16 |
---|
381 | | - | (3) Reporting to external agencies. 17 |
---|
382 | | - | (f) A dispute arising from the enforcement of this section shall be 18 |
---|
383 | | - | subject to a fair and prompt resolution process as defined by rule by the 19 |
---|
384 | | - | Insurance Commissioner. 20 |
---|
385 | | - | (g)(1) The commissioner may promulgate rules necessary to implement, 21 |
---|
386 | | - | administer, and enforce this section. 22 |
---|
387 | | - | (2) Rules that the commissioner may adopt under this section 23 |
---|
388 | | - | include without limitation rules relating to: 24 |
---|
389 | | - | (A) Resolving disputes that arise from enforcement of this 25 |
---|
390 | | - | section through a fair and prompt resolution process; and 26 |
---|
391 | | - | (B) Implementing a penalty structure for a healthcare 27 |
---|
392 | | - | payor or pharmacy benefits manager that fails to comply with this section 28 |
---|
393 | | - | that: 29 |
---|
394 | | - | (i) Is based on the number of Arkansas residents 30 |
---|
395 | | - | serviced by the healthcare payor or pharmacy benefits manager; and 31 |
---|
396 | | - | (ii) Does not exceed one hundred thousand dollars 32 |
---|
397 | | - | ($100,000) per violation. 33 |
---|
398 | | - | 34 |
---|
399 | | - | 23-92-515. Self-administered prescription drug — Definition 35 |
---|
400 | | - | controlling. 36 As Engrossed: H3/19/25 H4/1/25 SB104 |
---|
401 | | - | |
---|
402 | | - | 11 04-01-2025 14:34:50 ANS087 |
---|
403 | | - | |
---|
404 | | - | |
---|
405 | | - | (a) The definition of "self -administered prescription drug" under this 1 |
---|
406 | | - | subchapter is controlling, and that defined term shall not be altered, 2 |
---|
407 | | - | modified, reclassified, relabeled, or reinterpreted by a health benefit plan, 3 |
---|
408 | | - | healthcare payor, healthcare payor affiliate, pharmacy benefits manager, or 4 |
---|
409 | | - | pharmacy benefits manager affiliate. 5 |
---|
410 | | - | (b) A classification, labeling, or interpretation by a health benefit 6 |
---|
411 | | - | plan, healthcare payor, healthcare payor affiliate, pharmacy benefits 7 |
---|
412 | | - | manager, or pharmacy benefits manager affiliate does not override or 8 |
---|
413 | | - | supersede the definition of "self -administered prescription drug" under this 9 |
---|
414 | | - | subchapter. 10 |
---|
415 | | - | 11 |
---|
416 | | - | 23-92-516. Violation of Deceptive Trade Practices Act —Enforcement — 12 |
---|
417 | | - | Exclusions. 13 |
---|
418 | | - | (a) A prohibition of an activity under this subchapter is applicable 14 |
---|
419 | | - | to a person or entity that: 15 |
---|
420 | | - | (1) Performs the prohibited activity; 16 |
---|
421 | | - | (2) Causes another person or entity to perform the prohibited 17 |
---|
422 | | - | activity; 18 |
---|
423 | | - | (3) Solicits, advises, encourages, or coerces another person or 19 |
---|
424 | | - | entity to perform the prohibited activity; 20 |
---|
425 | | - | (4) Aids or attempts to aid another person or entity in 21 |
---|
426 | | - | performing a prohibited activity; or 22 |
---|
427 | | - | (5) Indirectly performs the prohibited activity. 23 |
---|
428 | | - | (b)(1) This subchapter does not require a self -funded health benefit 24 |
---|
429 | | - | plan to: 25 |
---|
430 | | - | (A) Alter existing covered benefits of the self -funded 26 |
---|
431 | | - | health benefit plan; or 27 |
---|
432 | | - | (B) Modify underlying plan terms of the self -funded health 28 |
---|
433 | | - | benefit plan. 29 |
---|
434 | | - | (2) However, to the extent not preempted by federal law, this 30 |
---|
435 | | - | section applies to the administration and business practices of pharmacy 31 |
---|
436 | | - | benefits within the state, including without limitation the conduct of 32 |
---|
437 | | - | pharmacy benefits managers and pharmacy benefits manager affiliates. 33 |
---|
438 | | - | (c)(1) If a pharmacy benefits manager imposes or represents any 34 |
---|
439 | | - | requirement or limitation as health -benefit-plan-imposed, the actual terms of 35 |
---|
440 | | - | the underlying health benefit plan document shall control. 36 As Engrossed: H3/19/25 H4/1/25 SB104 |
---|
441 | | - | |
---|
442 | | - | 12 04-01-2025 14:34:50 ANS087 |
---|
443 | | - | |
---|
444 | | - | |
---|
445 | | - | (2) The plan sponsor shall retain the authority to interpret and 1 |
---|
446 | | - | apply the health benefit plan sponsor's own health benefit plan’s terms to 2 |
---|
447 | | - | the extent permitted by applicable federal and state law. 3 |
---|
448 | | - | (d) If it is determined by the Insurance Commissioner that a pharmacy 4 |
---|
449 | | - | benefits manager or pharmacy benefits manager affiliate is operating outside 5 |
---|
450 | | - | the terms of the underlying health benefit plan, all dispute, enforcement, 6 |
---|
451 | | - | and penalties under this subchapter shall apply and may be enforced by the 7 |
---|
452 | | - | commissioner. 8 |
---|
453 | | - | SECTION 5. EMERGENCY CLAUSE. It is found and determined by the 9 |
---|
454 | | - | General Assembly of the State of Arkansas that an enrollee's access to 10 |
---|
455 | | - | prescription medications is of immediate concern; that undue restrictions on 11 |
---|
456 | | - | pharmacies and pharmacists hinder patient care; and that this act is 12 |
---|
457 | | - | immediately necessary to protect an enrollee's rights and ensure timely 13 |
---|
458 | | - | access to medications. Therefore, an emergency is declared to exist, and this 14 |
---|
459 | | - | act being immediately necessary for the preservation of the public peace, 15 |
---|
460 | | - | health, and safety shall become effective on: 16 |
---|
461 | | - | (1) The date of its approval by the Governor; 17 |
---|
462 | | - | (2) If the bill is neither approved nor vetoed by the Governor, 18 |
---|
463 | | - | the expiration of the period of time during which the Governor may veto the 19 |
---|
464 | | - | bill; or 20 |
---|
465 | | - | (3) If the bill is vetoed by the Governor and the veto is 21 |
---|
466 | | - | overridden, the date the last house overrides the veto. 22 |
---|
467 | | - | 23 |
---|
468 | | - | /s/C. Penzo 24 |
---|